ReviewThe American journal of case reports2026
Atypical Presentation of Exertional Rhabdomyolysis in Older Adults: Two Case Reports and Literature Review.
Review in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Rhabdomyolysis (RM) is caused by drugs, trauma, infection, and high-intensity exercise. As a subtype, exertional rhabdomyolysis (ER) is commonly triggered by high-intensity exercise and clinically manifests as myalgia, dark urine, and other symptoms. Auxiliary tests typically show elevated creatine kinase (CK) and myoglobin (Mb) levels. Aggressive rehydration is the primary treatment for RM. After fluid replacement therapy, serum CK levels usually decline rapidly. CASE REPORT We describe 2 patients with ER who displayed atypical symptoms induced by short-term high-intensity physical labor. Both patients initially presented with limb swelling and asthenia; they showed no myalgia or dark urine. The elevated CK levels in both patients were lower than the levels typically observed in ER cases but remained high for a prolonged period (1-3 months). After aggressive fluid replacement therapy, clinical symptoms gradually improved in both patients, and CK levels slowly decreased. Follow-up evaluations after discharge confirmed full recovery. Each patient presented with atypical clinical symptoms, modest elevation of serum CK, and a slow response to treatment, which collectively posed diagnostic challenges during the initial assessment. CONCLUSIONS This report demonstrates that some patients with ER may have a prolonged disease course, atypical clinical symptoms, lack of clinically significant increase in CK levels, and slow treatment response. Therefore, misdiagnosis may occur in clinical practice, particularly in primary healthcare settings or among clinicians with limited experience. These findings may provide useful data and clinical insight for the diagnosis and management of ER.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.